Use of atypical antipsychotics in the elderly: a clinical review
Open Access
- 1 August 2014
- journal article
- review article
- Published by Taylor & Francis Ltd in Clinical Interventions in Aging
- Vol. 9, 1363-73
- https://doi.org/10.2147/cia.s63942
Abstract
Use of atypical antipsychotics in the elderly: a clinical review Pietro Gareri,1 Cristina Segura-García,2 Valeria Graziella Laura Manfredi,1 Antonella Bruni,2 Paola Ciambrone,2 Gregorio Cerminara,2 Giovambattista De Sarro,2 Pasquale De Fazio2 1Elderly Health Care, Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy; 2Department of Health Sciences, University “Magna Græcia” of Catanzaro, Catanzaro, Italy The use of atypical antipsychotic drugs in the elderly has become wider and wider in recent years; in fact, these agents have novel receptor binding profiles, good efficacy with regard to negative symptoms, and reduced extrapyramidal symptoms. However, in recent years, the use of both conventional and atypical antipsychotics has been widely debated for concerns about their safety in elderly patients affected with dementia and the possible risks for stroke and sudden death. A MEDLINE search was made using the words elderly, atypical antipsychotics, use, schizophrenia, psychosis, mood disorders, dementia, behavioral disorders, and adverse events. Some personal studies were also considered. This paper reports the receptor binding profiles and the main mechanism of action of these drugs, together with their main use in psychiatry and the possible adverse events in elderly people. Keywords: atypical antipsychotics, dementia, elderly, psychosis, mood disorders, side effectsKeywords
This publication has 76 references indexed in Scilit:
- Thrombotic complications of treatment with antipsychotic drugs.2013
- Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-ADAmerican Journal of Psychiatry, 2011
- A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic DepressionArchives of General Psychiatry, 2009
- Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's diseaseMovement Disorders, 2005
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden DeathAmerican Journal of Psychiatry, 2001
- Olanzapine Use in the Elderly: A Retrospective AnalysisThe Canadian Journal of Psychiatry, 2000
- Olanzapine for Psychosis in Patients With Parkinson's Disease With and Without DementiaThe Journal of Neuropsychiatry and Clinical Neurosciences, 1999
- Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.1999
- Focus on QuetiapineCurrent Medical Research and Opinion, 1999